Uniqure NV Correlations
QURE Stock | USD 14.61 0.21 1.46% |
The current 90-days correlation between Uniqure NV and Regenxbio is 0.29 (i.e., Modest diversification). The correlation of Uniqure NV is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Uniqure NV Correlation With Market
Average diversification
The correlation between Uniqure NV and DJI is 0.17 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Uniqure NV and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Uniqure Stock
0.76 | FATE | Fate Therapeutics | PairCorr |
0.62 | PFE | Pfizer Inc Aggressive Push | PairCorr |
0.66 | INCR | INC Research Holdings | PairCorr |
0.78 | RCUS | Arcus Biosciences | PairCorr |
0.68 | CGEN | Compugen | PairCorr |
0.76 | AVAL | Grupo Aval | PairCorr |
0.7 | KB | KB Financial Group Earnings Call This Week | PairCorr |
0.65 | SHG | Shinhan Financial | PairCorr |
0.73 | BCH | Banco De Chile | PairCorr |
0.64 | WMT | Walmart | PairCorr |
0.69 | TRV | The Travelers Companies Earnings Call This Week | PairCorr |
0.61 | MSFT | Microsoft | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Uniqure Stock performing well and Uniqure NV Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Uniqure NV's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
RGNX | 5.20 | 0.30 | 0.09 | 0.37 | 6.22 | 13.43 | 36.09 | |||
DAWN | 2.60 | (0.30) | (0.06) | 0.00 | 3.38 | 6.18 | 18.22 | |||
REPL | 3.62 | 0.53 | 0.08 | 0.88 | 5.08 | 9.63 | 34.70 | |||
MIRM | 1.73 | 0.19 | 0.07 | 0.46 | 2.14 | 4.10 | 14.67 | |||
RCKT | 5.90 | (0.30) | 0.00 | (0.16) | 0.00 | 11.20 | 76.11 | |||
VYGR | 3.40 | (0.10) | 0.01 | 0.18 | 3.87 | 7.27 | 28.41 | |||
RARE | 2.53 | (0.29) | 0.00 | (0.03) | 0.00 | 6.20 | 34.27 | |||
BPMC | 1.94 | 0.68 | 0.38 | 1.75 | 0.73 | 5.43 | 26.28 |
Uniqure NV Corporate Management
Maria Cantor | Chief Officer | Profile | |
Carla Poulson | Interim Officer | Profile | |
Alexander Kuta | Ex Affairs | Profile | |
Ricardo Dolmetsch | Pres RD | Profile | |
Pierre Caloz | Chief Officer | Profile | |
Eileen Sawyer | Vice Affairs | Profile | |
Amin Abujoub | Chief Operations | Profile |